Request a Consultation Please fill out the form below:

Refer a Patient Please fill out the form below:

Contact Us Please fill out the form below:

Share your storyPlease fill out the form below:

Thank you for sharing

call us
              

 

  

Precision Targeting. Fewer Side Effects

Both standard X-ray (photon) radiation therapy and proton therapy attack tumors by preventing cancer cells from dividing and growing. The difference between the two therapies is that protons can precisely target the tumor, allowing patients to receive higher, more effective doses, and reducing damage to healthy tissue near the tumor.1 Watch the video »

Click image above to enlarge.

Research shows that proton therapy can cause fewer short- and long-term side effects than standard radiation therapy, reducing the occurrence of secondary tumors and improving quality of life for patients.4-9


Benefits at a glance1-9

  • Causes fewer short- and long-term side effects
  • Proven to be effective in adults and children
  • Targets tumors and cancer cells with precision, reducing the risk of damage to surrounding healthy tissues and organs
  • Reduces the likelihood of secondary tumors caused by treatment
  • Can be used to treat recurrent tumors even in patients who have already received radiation
  • Improves quality of life during and after treatment

References

  1. Fowler JF. What can we expect from dose escalation using proton beams. Clin Oncol. 2003;15(1):S10-S15.
  2. Vernimmen FJ, Harris JK, Wilson JA, Melvill R, Smit BJ, Slabbert JP. Stereotactic proton beam therapy of skull base meningiomas. Int J Radiat Oncol Biol Phys. 2001;49(1):99-105.
  3. Bolsi A, Fogliata A, Cozzi L. Radiotherapy of small intracranial tumours with different advanced techniques using photon and proton beams: a treatment planning study. Radiother Oncol. 2003;68:1-14.
  4. Steneker M, Lomax A, Schneider U. Intensity modulated photon and proton therapy for the treatment of head and neck tumors. Radiother Oncol. 2006;80(2):263-267.
  5. Miralbell R, Lomax A, Cella L, Scheider U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys. 2002;54(3):824-829.
  6. Chung CS, Keating N, Yock T, Tarbell N. Comparative analysis of second malignancy risk in patients treated with proton therapy versus conventional photon therapy. Int J Radiat Oncol Biol Phys. 2008;72(1):S8.
  7. Lee CT, Bilton SD, Famiglietti RM, et al. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys. 2005;63(2):362-372.
  8. Komaki R, Sejpal S, Wei X, et al. Reduction of bone marrow suppression for patients with stage III NSCLC treated by proton and chemotherapy compared with IMRT and chemotherapy. Particle Therapy Cooperative Group 47. 2008;O10:14.
  9. Mayahara H, Murakami M, Kagawa K, et al. Acute morbidity of proton therapy for prostate cancer: the Hyogo Ion Beam Medical Center experience. Int J Radiat Oncol Biol Phys. 2007;69(2):434-443.